{
      "Rank": 1,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for autoimmune conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for cardiovascular disorders and conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for diabetes complications. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for integumentary diseases and conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for orthopedic and musculoskeletal conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for neurologic and neurodegenerative disorders. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for pulmonary disorders. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for sexual dysfunction conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for urologic conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.",
            "Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for viral illnesses. Outcomes will be compared to results in peer-reviewed literature for several conditions."
      ],
      "ArmGroupInterventionName": [
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122",
            "Biological: PrimePro\u2122/ PrimeMSK\u2122"
      ],
      "ArmGroupLabel": [
            "Arm 1: Autoimmune Diseases",
            "Arm 2: Cardiovascular Disorders",
            "Arm 3: Diabetes Complications",
            "Arm 4: Integumentary Disease",
            "Arm 5: Musculoskeletal Disorders",
            "Arm 6: Neurodegenerative Disorders",
            "Arm 7: Pulmonary Disorders",
            "Arm 8: Sexual Dysfunction",
            "Arm 9: Urologic Disorders",
            "Arm 10: Viral Illnesses"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental",
            "Experimental",
            "Experimental",
            "Experimental",
            "Experimental",
            "Experimental",
            "Experimental",
            "Experimental",
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT04684602"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions."
      ],
      "BriefTitle": [
            "Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions"
      ],
      "CentralContactEMail": [
            "paul@thomasadvancedmedical.com",
            "karen@thomasadvancedmedical.com"
      ],
      "CentralContactName": [
            "Paul C Bogaardt, PhD(c), MSc, MBA",
            "Karen Mulholland Angelus"
      ],
      "CentralContactPhone": [
            "866 864 7789",
            "866 864 7789"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [
            "UNKNOWN",
            "UNKNOWN"
      ],
      "CollaboratorName": [
            "HeartStem Institute",
            "NuStem"
      ],
      "CompletionDate": [
            "December 9, 2030"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Autoimmune Diseases",
            "Cardiovascular Disorders",
            "Diabetes Complications",
            "Integumentary Disease",
            "Musculoskeletal Disorders",
            "Neurodegenerative Disorders",
            "Neurologic Disorders",
            "Pulmonary Disorders",
            "Sexual Dysfunction",
            "Urologic Disorders",
            "Viral Illness"
      ],
      "ConditionAncestorId": [
            "D000010335",
            "D000007154",
            "D000003920",
            "D000004700",
            "D000012140"
      ],
      "ConditionAncestorTerm": [
            "Pathologic Processes",
            "Immune System Diseases",
            "Diabetes Mellitus",
            "Endocrine System Diseases",
            "Respiratory Tract Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC18",
            "BC19",
            "All",
            "BC08",
            "BC10",
            "BXM",
            "BC14",
            "BC01",
            "BC20",
            "BXS",
            "BC05",
            "BC17",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Nutritional and Metabolic Diseases",
            "Gland and Hormone Related Diseases",
            "All Conditions",
            "Respiratory Tract (Lung and Bronchial) Diseases",
            "Nervous System Diseases",
            "Behaviors and Mental Disorders",
            "Heart and Blood Diseases",
            "Infections",
            "Immune System Diseases",
            "Urinary Tract, Sexual Organs, and Pregnancy Conditions",
            "Musculoskeletal Diseases",
            "Skin and Connective Tissue Diseases",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Pulmonary Disorder",
            "Autoimmune Diseases",
            "Musculoskeletal Disorders",
            "Integumentary Disease",
            "Neurodegenerative Disorders",
            "Diabetes Complications"
      ],
      "ConditionBrowseLeafId": [
            "M6267",
            "M10320",
            "M6056",
            "M11306",
            "M2562",
            "M20989",
            "M13625",
            "M3967",
            "M8571",
            "M3037",
            "M16674",
            "M4356",
            "M3781",
            "M12584",
            "M9352",
            "M16471",
            "M11249",
            "M14826",
            "M9369",
            "M11563",
            "M20711",
            "M4894",
            "M22155",
            "M25157",
            "M7014",
            "M14129",
            "T2192",
            "T1303",
            "T170"
      ],
      "ConditionBrowseLeafName": [
            "Diabetes Mellitus",
            "Lung Diseases",
            "Dementia",
            "Cardiomyopathies",
            "COVID-19",
            "Neurocognitive Disorders",
            "Psychotic Disorders",
            "Mental Disorders",
            "Heart Diseases",
            "Alzheimer Disease",
            "Virus Diseases",
            "Brain Diseases",
            "Autoimmune Diseases",
            "Peripheral Nervous System Diseases",
            "Immune System Diseases",
            "Urologic Diseases",
            "Musculoskeletal Diseases",
            "Skin Diseases",
            "Erectile Dysfunction",
            "Neuromuscular Diseases",
            "Neurodegenerative Diseases",
            "Central Nervous System Diseases",
            "Tauopathies",
            "Diabetes Complications",
            "Endocrine System Diseases",
            "Respiratory Tract Diseases",
            "Familial Alzheimer Disease",
            "Chronic Graft Versus Host Disease",
            "Acute Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low",
            "low",
            "high",
            "high",
            "low",
            "low",
            "high",
            "low",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000009140",
            "D000008171",
            "D000009422",
            "D000019636",
            "D000002318",
            "D000012871",
            "D000048909",
            "D000001327",
            "D000004194"
      ],
      "ConditionMeshTerm": [
            "Musculoskeletal Diseases",
            "Lung Diseases",
            "Nervous System Diseases",
            "Neurodegenerative Diseases",
            "Cardiovascular Diseases",
            "Skin Diseases",
            "Diabetes Complications",
            "Autoimmune Diseases",
            "Disease"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Non-Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [
            "This is a multi-center, prospective, open label clinical trial. It will include 5000 patients suffering acute and chronic conditions under 10 different categories. Patients will undergo a single treatment with a biological tissue allograft and will be followed for 12 months."
      ],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.\n\nThis study investigates clinical outcomes of treatments for numerous indications including: Autoimmune, Cardiovascular, Diabetes, Integumentary, Neurologic / Neurodegenerative, Pulmonary, Orthopedic Diseases, Sexual Dysfunction, Urologic Disorders and Viral Illnesses.\n\nOur hypotheses posit that regenerative treatments are both safe and statistically beneficial for a range of conditions. Outcomes will be determined by multiple valid outcome instruments that measure general quality of life information along with condition-specific information."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nAge 18 and older\nAbility to provide informed consent\nAvailability for follow up visits\n\nExclusion Criteria:\n\nActive or recent malignancy (within last 2 years)\nPregnancy or breast-feeding\nInability to provide informed consent"
      ],
      "EnrollmentCount": [
            "5000"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "Accepts Healthy Volunteers"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [
            "Data will be blinded and password protected. Research publications will be produced for medical journals. Participating Investigators will have password protected access only."
      ],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Arm 10: Viral Illnesses",
            "Arm 1: Autoimmune Diseases",
            "Arm 2: Cardiovascular Disorders",
            "Arm 3: Diabetes Complications",
            "Arm 4: Integumentary Disease",
            "Arm 5: Musculoskeletal Disorders",
            "Arm 6: Neurodegenerative Disorders",
            "Arm 7: Pulmonary Disorders",
            "Arm 8: Sexual Dysfunction",
            "Arm 9: Urologic Disorders"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Injection via condition specific route of administration."
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "PrimePro\u2122/ PrimeMSK\u2122"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "Yes"
      ],
      "IsPPSD": [],
      "IsUSExport": [
            "Yes"
      ],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "stem cell therapy",
            "umbilical cord stem cells",
            "amniotic stem cells",
            "stem cells",
            "MSC",
            "Mesenchymal Stem Cell",
            "Medicinal Signaling Cell",
            "Erectile Dysfunction",
            "Heart Diseases",
            "Mental Disorders",
            "Neurocognitive Disorders",
            "Neurodegenerative Diseases",
            "Central Nervous System Diseases",
            "Tauopathies",
            "Brain Diseases",
            "Dementia",
            "Disease",
            "Cardiomyopathies",
            "Urologic Diseases",
            "Peripheral Nervous System Diseases",
            "Nervous System Diseases",
            "Alzheimer Disease",
            "Musculoskeletal Diseases",
            "Cardiovascular Diseases",
            "Immune System Diseases",
            "Neuromuscular Diseases",
            "Covid-19"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "April 29, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "April 27, 2022"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Thomas Advanced Medical LLC"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Culver City"
      ],
      "LocationContactEMail": [
            "info@thomasadvancedmedical.com",
            "info@thomasadvancedmedical.com"
      ],
      "LocationContactName": [
            "Karen Mulholland Angelus",
            "Ernst R Von Shwarz, MD PhD"
      ],
      "LocationContactPhone": [
            "866-864-7789",
            "866 864 7789"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Contact"
      ],
      "LocationCountry": [
            "United States"
      ],
      "LocationFacility": [
            "Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites"
      ],
      "LocationState": [
            "California"
      ],
      "LocationStatus": [
            "Recruiting"
      ],
      "LocationZip": [
            "92032"
      ],
      "MaximumAge": [],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Thomas Advanced Medical LLC"
      ],
      "OrgStudyId": [
            "ICSS-2020-032"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "HeartStem Institute, Southern California Hospital at Culver City"
      ],
      "OverallOfficialName": [
            "Ernst R Von Schwarz, MD, PhD"
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "July 9, 2030"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "General Health Outcome Instrument used to derive a simple psychometric score for health related quality of life which provides scores on various dimensions or items describing the systems. The score is derived by adding the unweighted response order of each question, with a lower score denoting a better quality of life.",
            "Upper Extremity Outcome Instrument",
            "Erectile Function Questionnaire. Scoring exists from 0 to 25. The lower the score, the more severe the Erectile Dysfunction.",
            "COPD Outcome Instrument. Items are scored on a Likert scale (range 0-60). Higher scores indicate a worse health status.",
            "Memory Outcome Instrument. The maximum MMSE score is 30 points. The lower the score, the more severe the dementia.",
            "Voiding and Pain Indices. Possible score of 0-20 with higher scores denoting better function.",
            "Low Back Pain Outcome Instrument. Possible score of 0-100 with lower scores denoting better function.",
            "Arthritis Outcome Instrument. Individual question scores are then summed to form a raw score ranging from 0 (worst) to 96 (best)"
      ],
      "PrimaryOutcomeMeasure": [
            "Assessment of quality of life (QOL) via 36-Item Short Form Survey (SF-36) change from baseline at 6 and 12 months.",
            "Assessment of disabilities of arm, shoulder, hand via DASH Questionnaire change from baseline at 6 and 12 months.",
            "Assessment of erectile function via International Index of Erectile Function (IIEF-5) change from baseline at 6 and 12 months.",
            "Assessment of COPD via Clinical Chronic Obstructive Pulmonary Disease Questionnaire change from baseline at 6 and 12 months.",
            "Assessment of mental state via Mini Mental State Examination (MMSE) change from baseline at 6 and 12 months.",
            "Assessment of interstitial cystitis via O'Leary/Sant Questionnaire change from baseline at 6 and 12 months.",
            "Assessment of back pain via Oswestry Low Back Pain Disability Questionnaire change from baseline at 6 and 12 months.",
            "Assessment of osteoarthritis via Western Ontario and McMaster Osteoarthritis Index (WOMAC) change from baseline at 6 and 12 months."
      ],
      "PrimaryOutcomeTimeFrame": [
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.",
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.",
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.",
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.",
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.",
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.",
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.",
            "Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months."
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [],
      "SecondaryOutcomeTimeFrame": [],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "July 9, 2020"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "April 2022"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "December 24, 2020"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "December 2, 2020"
      ],
      "StudyFirstSubmitQCDate": [
            "December 22, 2020"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 07, 2022"
      ],
      "WhyStopped": []
}